Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Recent Advances in Glioblastoma Multiforme Therapy: A Focus on Autophagy Regulation Publisher Pubmed



Sanati M1, 2 ; Binabaj MM3 ; Ahmadi SS4 ; Aminyavari S5 ; Javid H6 ; Mollazadeh H4 ; Bibak B7 ; Mohtashami E7 ; Jamialahmadi T8, 9 ; Afshari AR4, 7 ; Sahebkar A8, 10, 11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran
  2. 2. Experimental and Animal Study Center, Birjand University of Medical Sciences, Birjand, Iran
  3. 3. Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
  4. 4. Department of Physiology and Pharmacology, Faculty of Medicine, North Khorasan ‎University of Medical Sciences, Bojnurd, Iran
  5. 5. Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran
  7. 7. Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran
  8. 8. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  9. 9. Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  10. 10. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  11. 11. Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Biomedicine and Pharmacotherapy Published:2022


Abstract

Despite conventional treatment options including chemoradiation, patients with the most aggressive primary brain tumor, glioblastoma multiforme (GBM), experience an average survival time of less than 15 months. Regarding the malignant nature of GBM, extensive research and discovery of novel treatments are urgently required to improve the patients’ prognosis. Autophagy, a crucial physiological pathway for the degradation and recycling of cell components, is one of the exciting targets of GBM studies. Interventions aimed at autophagy activation or inhibition have been explored as potential GBM therapeutics. This review, which delves into therapeutic techniques to block or activate autophagy in preclinical and clinical research, aims to expand our understanding of available therapies battling GBM. © 2022 The Authors
Other Related Docs
10. Metastatic Outgrowth Via the Two-Way Interplay of Autophagy and Metabolism, Biochimica et Biophysica Acta - Molecular Basis of Disease (2024)
16. Exosomes, Autophagy and Er Stress Pathways in Human Diseases: Cross-Regulation and Therapeutic Approaches, Biochimica et Biophysica Acta - Molecular Basis of Disease (2022)
19. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
29. Quercetin and Glioma: Which Signaling Pathways Are Involved?, Current Molecular Pharmacology (2022)
33. Virus, Exosome, and Microrna: New Insights Into Autophagy, Advances in Experimental Medicine and Biology (2022)
35. Advantages and Drawbacks of Dexamethasone in Glioblastoma Multiforme, Critical Reviews in Oncology/Hematology (2022)
39. The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (Aml)?, International Journal of Hematology-Oncology and Stem Cell Research (2022)
45. Therapeutic Potentials of Curcumin in the Treatment of Glioblstoma, European Journal of Medicinal Chemistry (2020)